» Articles » PMID: 35862720

Expression of CD117 (c-Kit) on Circulating B Cells in Pediatric Schistosomiasis

Abstract

Few B cells express CD27, the primary marker for memory B cells, in pediatric schistosomiasis, suggesting B cell malfunction. This study further demonstrates unexpected high expression of CD117 on circulating B cells in children highly exposed to Schistosoma mansoni infectious larvae. CD117 is expressed by immature or lymphoma B cells, but not by mature, circulating cells. We therefore sought to define the significance of CD117 on blood B cells. We found that CD117-positive (CD117) B cells increased with the intensity of schistosome infection. In addition, CD117 expression was reduced on CD23 B cells previously shown to correlate with resistance to infection. Stimulation with a panel of cytokines demonstrated that CD117 levels were upregulated in response to a combination of interleukin 4 (IL-4) and stem cell factor (SCF), the ligand for CD117, whereas IL-2 led to a reduction. In addition, stimulation with SCF generally reduced B cell activation levels. Upon further investigation, it was established that multiple circulating cells expressed increased levels of CD117, including monocytes, neutrophils, and eosinophils, and expression levels correlated with that of B cells. Finally, we identified a population of large circulating cells with features of reticulocytes. Overall, our results suggest that hyperexposure to intravascular parasitic worms elicits immature cells from the bone marrow. Levels of SCF were shown to reduce as children began to transition through puberty. The study results pose an explanation for the inability of children to develop significant immunity to infection until after puberty.

Citing Articles

ILC3: a case of conflicted identity.

Koprivica I, Stanisavljevic S, Micanovic D, Jevtic B, Stojanovic I, Miljkovic D Front Immunol. 2023; 14:1271699.

PMID: 37915588 PMC: 10616800. DOI: 10.3389/fimmu.2023.1271699.

References
1.
Wami W, Nausch N, Bauer K, Midzi N, Gwisai R, Simmonds P . Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes. Parasitology. 2014; 141(14):1962-70. PMC: 4255325. DOI: 10.1017/S0031182014000213. View

2.
Rodriguez-Galan A, Fernandez-Messina L, Sanchez-Madrid F . Control of Immunoregulatory Molecules by miRNAs in T Cell Activation. Front Immunol. 2018; 9:2148. PMC: 6167432. DOI: 10.3389/fimmu.2018.02148. View

3.
Samuels A, Matey E, Mwinzi P, Wiegand R, Muchiri G, Ireri E . Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya. Am J Trop Med Hyg. 2012; 87(5):874-82. PMC: 3516263. DOI: 10.4269/ajtmh.2012.12-0397. View

4.
Asito A, Piriou E, Jura W, Ouma C, Odada P, Ogola S . Suppression of circulating IgD+CD27+ memory B cells in infants living in a malaria-endemic region of Kenya. Malar J. 2011; 10:362. PMC: 3315680. DOI: 10.1186/1475-2875-10-362. View

5.
Muraguchi A, Kehrl J, Longo D, Volkman D, Smith K, Fauci A . Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med. 1985; 161(1):181-97. PMC: 2187555. DOI: 10.1084/jem.161.1.181. View